Kraig Biocraft Laboratories

KBLB · OTC

$0.0813+$0.0002 (+0.25%)TodayMarket closed ·
Prev close $0.0811

About KBLB

Kraig Biocraft Laboratories, Inc. operates as a biotechnology company, which focuses on the development and commercialization of spider silk. The company is headquartered in Ann Arbor, Michigan and currently employs 7 full-time employees. The company went IPO on 2008-02-29. The firm uses genetically engineered silkworms that produce spider silk proteins to create its recombinant spider silk. Its primary fiber technology includes natural and engineered variants of spider silk produced from domesticated mulberry silkworms. The Company’s products use the characteristics of spider silk, specifically dragline silk from Nephila clavipes and variants thereof. Its applications include performance apparel, workwear, filtration, luxury fashion, flexible composites, medical implants, cosmetics and more. Its products include Monster Silk, Dragon Silk, and other products. Its recombinant spider silk fiber blends the silk proteins found in spider silk with the native silkworm silk proteins. The company also focuses on developing new recombinant silks and other protein-based fibers and materials.

Employees
7
Headquarters
Ann Arbor, Michigan
Listed
Feb 29, 2008
Sector
Materials
Industry
Chemicals

KBLB key statistics

Market cap
90.68M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
1.63M
Volume
1.24M
Open price
$0.0811
High today
$0.0878
Low today
$0.0808
52 Week high
$0.16
52 Week low
$0.065

Kraig Biocraft Laboratories (KBLB) at a glance

Kraig Biocraft Laboratories (KBLB) last traded at $0.0813, with a market cap of 90.68M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $0.0808 and $0.0878. The current price is 0.6% above the day's low and 7.4% below its high.

Volume so far is 1.24M shares, below the average of 1.63M shares a day.

Over the past year Kraig Biocraft Laboratories has ranged from $0.065 to $0.16, and now sits 17% of the way up that range.

KBLB news

  • Press releaseGlobe Newswire

    Kraig Biocraft Laboratories Selected to Present to the International Sericultural Commission Congress on the Impact of Bioengineering on Commercial Silk Markets

  • Press releaseGlobe Newswire

    What’s More Space Age Than Spider Silk Spun by Kraig Labs’ Transgenic Silkworms?

  • Press releaseGlobe Newswire

    Four Companies Racing to Turn Innovation into Revenue

  • Press releaseGlobe Newswire

    Kraig Labs Races to Scale Production as Billion-Dollar High-Performance Materials Market Starved for Scalable Supply Beckons

  • Press releaseGlobe Newswire

    Kraig Biocraft Laboratories Files for Expanded Investment License to Fuel Spider Silk Production Growth

  • Press releaseGlobe Newswire

    Commercial Orders, FDA Firepower and Crypto Momentum

  • Press releaseGlobe Newswire

    Kraig Biocraft Laboratories Ramps Full Production Across All Three Production Centers as Commercial Deliveries Begin to Take Hold

  • Press releaseGlobe Newswire

    These Stocks Roar into October with Fresh Catalysts

Similar companies

Companies in the same industry as Kraig Biocraft Laboratories

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.